Earnings Feed
Start Free
Home/Filings/3/0000899243-19-026384
3//SEC Filing

Versant Vantage I GP-GP, LLC 3

Accession 0000899243-19-026384

CIK 0001720725other
View on SEC.govCompany Profile

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 8:05 PM ET

Size

27.1 KB

Accession

0000899243-19-026384

Insider Transaction Report

Form 3
Period: 2019-10-30
Oyster Point Pharma, Inc.OYST
Versant Ventures IV, LLC
10% Owner
Holdings

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (10,420 underlying)

  • Series A Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (1,941,500 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock, par value $0.001 per share (566,158 underlying)

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (1,654,359 underlying)

  • Series B Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (495,388 underlying)

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    2,018

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    320,439
Versant Venture Capital IV, L.P.
10% Owner
Holdings

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    2,018

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    320,439

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (10,420 underlying)

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (1,654,359 underlying)

  • Series A Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (1,941,500 underlying)

  • Series B Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (495,388 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock, par value $0.001 per share (566,158 underlying)
Versant Side Fund IV, L.P.
10% Owner
Holdings

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (1,654,359 underlying)

  • Series A Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (1,941,500 underlying)

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    2,018

  • Series B Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (495,388 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock, par value $0.001 per share (566,158 underlying)

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    320,439

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (10,420 underlying)
Versant Vantage I, L.P.
10% Owner
Holdings

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock, par value $0.001 per share (566,158 underlying)

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    320,439

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (1,654,359 underlying)

  • Series A Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (1,941,500 underlying)

  • Series B Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (495,388 underlying)

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (10,420 underlying)

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    2,018
Versant Vantage I GP-GP, LLC
10% Owner
Holdings

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    2,018

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (10,420 underlying)

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (1,654,359 underlying)

  • Series A Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (1,941,500 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock, par value $0.001 per share (566,158 underlying)

  • Series B Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (495,388 underlying)

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    320,439
Versant Vantage I GP, L.P.
10% Owner
Holdings

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (10,420 underlying)

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    2,018

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    320,439

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (1,654,359 underlying)

  • Series A Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (1,941,500 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock, par value $0.001 per share (566,158 underlying)

  • Series B Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (495,388 underlying)
Versant Venture Capital VI, L.P.
10% Owner
Holdings

  • Series B Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (495,388 underlying)

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    2,018

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    320,439

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (10,420 underlying)

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (1,654,359 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock, par value $0.001 per share (566,158 underlying)

  • Series A Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (1,941,500 underlying)
Versant Ventures VI GP, L.P.
10% Owner
Holdings

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    2,018

  • Series B Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (495,388 underlying)

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (10,420 underlying)

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    320,439

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (1,654,359 underlying)

  • Series A Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (1,941,500 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock, par value $0.001 per share (566,158 underlying)
Versant Ventures VI GP-GP, LLC
10% Owner
Holdings

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (1,654,359 underlying)

  • Series B Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (495,388 underlying)

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    2,018

  • Common Stock, par value $0.001 per share

    (indirect: See footnotes)
    320,439

  • Series A Convertible Preferred Stock

    (indirect: See footnotes)
    → Common Stock, par value $0.001 per share (10,420 underlying)

  • Series A Convertible Preferred Stock

    → Common Stock, par value $0.001 per share (1,941,500 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock, par value $0.001 per share (566,158 underlying)
Footnotes (6)
  • [F1]Shares held by Versant Side Fund IV, L.P. ("Versant Side Fund IV").
  • [F2]Shares held by Versant Venture Capital IV, L.P. ("Versant IV").
  • [F3]Versant Ventures IV, LLC ("Versant Ventures IV") is the sole general partner of each of Versant IV and Versant Side Fund IV. Each of Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, Kirk G. Nielsen, Thomas F. Woiwode and Robin L. Praeger, as managing members of Versant Ventures IV, may be deemed to share voting and dispositive power over the shares held by Versant IV and Versant Side Fund IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports.
  • [F4]These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, "Preferred Stock") will automatically be converted into shares of the Issuer's common stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock has no expiration date.
  • [F5]Shares directly held by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Each of Bradley J. Bolzon, Jerel C. Davis, Kirk G. Nielsen, Robin L. Praeger and Thomas F. Woiwode, as managing members of Versant Ventures VI GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant VI; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein.
  • [F6]Shares held by Versant Vantage I, L.P. ("Versant Vantage"). Versant Vantage I GP, L.P. ("Versant Vantage I GP") is the general partner of Versant Vantage, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP. Each of Bradley J. Bolzon, Jerel C. Davis, Clare Ozawa, Robin L. Praeger and Thomas F. Woiwode, as managing members of Versant Vantage I GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant Vantage; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly, files separate Section 16 reports.

Documents

1 file

Issuer

Oyster Point Pharma, Inc.

CIK 0001720725

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001777653

Filing Metadata

Form type
3
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 8:05 PM ET
Size
27.1 KB
View on SEC.gov